» Articles » PMID: 19361505

Heparin-binding EGF-like Growth Factor Increases Intestinal Microvascular Blood Flow in Necrotizing Enterocolitis

Overview
Specialty Gastroenterology
Date 2009 Apr 14
PMID 19361505
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in neonates. Although the exact etiology remains unknown, decreased intestinal blood flow is believed to play a critical role. We have shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF) protects the intestines from injury in a rodent model of NEC. Our current goal was to assess the effect of HB-EGF on intestinal microvascular blood flow and intestinal injury in rat pups subjected to experimental NEC.

Methods: Newborn rat pups were subjected to stress by exposure to hypoxia, hypothermia, hypertonic feedings, and lipopolysaccharide, with some pups receiving HB-EGF (800 microg x kg(-1) x dose(-1)) added to the feeds. Control animals received breast milk. Intestinal injury was graded using a standard histologic injury scoring system. Microvascular blood flow was assessed by fluorescein isothiocyanate/dextran angiography, with fluorescent images subjected to quantification, and by scanning electron microscopy.

Results: Intestinal microvascular blood flow (defined as the extent of vascular filling with fluorescein isothiocyanate/dextran) was significantly decreased in pups subjected to stress compared with breast-fed pups. Stressed pups treated with HB-EGF had significantly increased microvascular blood flow. The changes in villous microvasculature correlated with histologic injury scores, with stressed pups treated with HB-EGF showing decreased histologic injury.

Conclusions: HB-EGF significantly preserved intestinal microvascular blood flow in pups subjected to experimental NEC, indicating that HB-EGF may play a critical role in the treatment of various diseases manifested by decreased intestinal blood flow, including NEC.

Citing Articles

Butyrate protects the intestinal barrier by upregulating Fut2 expression via MEK4-JNK signaling pathway activation.

Zhang D, Huang Z, Liu X, Ding X, Li L, He Y Pediatr Res. 2024; 97(1):128-137.

PMID: 39134757 DOI: 10.1038/s41390-024-03419-6.


alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway.

Chen Z, Chen H, Huang W, Guo X, Yu L, Shan J Gut Microbes. 2024; 16(1):2379566.

PMID: 39013030 PMC: 11253882. DOI: 10.1080/19490976.2024.2379566.


miR-375-3p targets YWHAB to attenuate intestine injury in neonatal necrotizing enterocolitis.

Nan L, Kaisi F, Mengzhen Z, Yang Y, Jiaming Y, Huirong Y Pediatr Surg Int. 2024; 40(1):63.

PMID: 38431920 DOI: 10.1007/s00383-024-05653-9.


Necrotizing enterocolitis: recent advances in treatment with translational potential.

Ganji N, Li B, Lee C, Pierro A Pediatr Surg Int. 2023; 39(1):205.

PMID: 37247104 DOI: 10.1007/s00383-023-05476-0.


β-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota.

Zhang X, Zhang Y, He Y, Zhu X, Ai Q, Shi Y J Transl Med. 2023; 21(1):14.

PMID: 36627673 PMC: 9830848. DOI: 10.1186/s12967-022-03866-x.


References
1.
Besner G, Higashiyama S, Klagsbrun M . Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1990; 1(11):811-9. PMC: 362848. DOI: 10.1091/mbc.1.11.811. View

2.
Matheson P, Wilson M, Garrison R . Regulation of intestinal blood flow. J Surg Res. 2000; 93(1):182-96. DOI: 10.1006/jsre.2000.5862. View

3.
Hashimoto K, Higashiyama S, Asada H, Hashimura E, Kobayashi T, Sudo K . Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem. 1994; 269(31):20060-6. View

4.
Kuhn M, Xia G, Mehta V, Glenn S, Michalsky M, Besner G . Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal. 2002; 4(4):639-46. DOI: 10.1089/15230860260220148. View

5.
Stappenbeck T, Hooper L, Gordon J . Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A. 2002; 99(24):15451-5. PMC: 137737. DOI: 10.1073/pnas.202604299. View